/ HCWB
/ Market Analysis
HCWB Stock Soars 82% on Breakthrough Cancer Therapy Results
HCW Biologics stock jumped 82% in premarket trading after reporting positive results for its next-generation T-cell engagers.
September 12, 2025
Why did HCW Biologics Shares Skyrocket in Today’s Trading Session?
HCW Biologics stock surged 85.5% after announcing a breakthrough second-generation immune checkpoint inhibitor that outperformed existing cancer treatments.
August 25, 2025
Back to 
